Hubungan Komorbiditas Terhadap Derajat Keparahan Admisi Dan Outcome Pasien Covid-19

Putra, I Made Adi Ananda; Fenty, Fenty

doi:10.52232/jhpsm.v1i1.57

Cited by 3 publications

(4 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Indonesia itself reported this case for the first time on March 2, 2020 (Aeni, 2021). There were 2 cases, and it continued to grow until June 20, 2023, when there were 6,811,429 confirmed cases with 161,918 deaths (Putra & Fenty, 2022).…”

Section: Introductionmentioning

confidence: 91%

“…Hypertension is a disease that is found in many people with Covid-19. This disease places a relatively high risk in the COVID-19 infection process (Putra & Fenty, 2022;Susilo et al, 2022;Yuliana, 2020). Hypertension itself is a condition of increased diastolic blood pressure >90mmHg and systolic >140mmHg with a number of two measurements for five minutes when in calm conditions.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Relationship of Hypertension with Death in Covid-19 Patients Treated at Tugurejo Hospital Semarang

Pramudhita,

Setyoko,

Pratama

2024

JISS

View full text Add to dashboard Cite

Covid-19 is a disease caused by SARS-CoV-2. Hypertension is a comorbidity that can be experienced by COVID-19 patients and is associated with an increased risk of severity and death. The purpose of this study is to look at the relationship between hypertension and death in COVID-19 patients treated at Tugurejo Hospital Semarang. This study is a quantitative study that uses an analytical observational design and a cross-sectional approach. The sampling technique was purposive sampling (judgment sampling) on 84 COVID-19 patients treated at Tugurejo Hospital Semarang for the May-November 2021 period. Data were obtained from medical records and analyzed univariately and bivariately with the Chi-Square test. Most patients were aged ≥50 years (40.5%), male (53.6%), high school educated (51.2%), employed as private employees (42.9%), suffered from hypertension (53.6%) and did not experience death (51.2%). The Chi-Square test resulted in a significant association between hypertension and death of COVID-19 patients (p = 0.031). There is an essential relationship between hypertension and death in COVID-19 patients at Tugurejo Hospital Semarang.

show abstract

Section: Introductionmentioning

confidence: 91%

Section: Introductionmentioning

confidence: 99%

The Relationship of Hypertension with Death in Covid-19 Patients Treated at Tugurejo Hospital Semarang

Pramudhita,

Setyoko,

Pratama

2024

JISS

View full text Add to dashboard Cite

show abstract

“…Data ini sejalan dengan penelitian oleh Khairunnisa et al, 2022. dalam penelitian tersebut, didapatkan sebanyak 59,5% subjek tidak memiliki komorbid dan sebanyak 40.5% Subjek memiliki komorbid (Khaerunnisa et al, 2022). Sedangkan hasil yang tidak sejalan didapatkan oleh Putra et al, (2022), dalam penelitian tersebut, sebanyak 60,7% pasien memiliki komorbid dan sebanyak 39,3% pasien tidak memiliki komorbid (Putra danFenty, 2022).…”

Section: Komorbidunclassified

“…Hasil penelitian serupa dapat ditemukan pada penelitian oleh putra dan fenty, dalam penelitian tersebut, didapatkan (p-value = <0,001). Sehingga dapat disimpulkan bahwa terdapat perbedaan signifikan pada pasien yang memiliki komorbid dan derajat admisi (Putra and Fenty, 2022).…”

Section: Hubungan Komorbiditas Terhadap Berat Gejala Covid-19unclassified

Relationship of Comorbidity and Age to the Severity of Clinical Symptoms of COVID-19 at Mataram University Hospital

Mahayasa

Hidayat

Fathana

et al. 2023

JBT

View full text Add to dashboard Cite

COVID-19 disease is a disease that arises due to infection with the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The purpose of this study was to determine differences in clinical symptoms in elderly and non-elderly patients, as well as patients who had comorbidities and did not have comorbidities. This research is a type of cross-sectional study that was conducted by reviewing the medical records of COVID-19 patients undergoing treatment at Mataram University Hospital in 2021. Data was collected using a consecutive sampling technique. The statistical test used is the Chi-square comparative test. To assess the relationship of age and comorbidities to the severity of symptoms in COVID-19 patients. In this study, 86 subjects were selected based on the inclusion and exclusion criteria applied. The majority of subjects were in the 15-59 year age group, namely 66 (23.3%). With male sex 51 (60.5%) people. The majority of patients with comorbidities experienced severe/critical symptoms 16 (44.4%) and patients without comorbids experienced no symptoms or experienced mild symptoms 35 (35%). The majority of elderly patients experienced severe-critical symptoms 9 (45%) and the majority of non-elderly patients experienced no symptoms or experienced mild symptoms 42 (63.6%). The results of the bivariate analysis test showed a p-value = 0.001 for comorbids with severe symptoms, and a p-value = 0.003 for age with severe symptoms. There is a significant relationship between comorbidities and age on the severity of symptoms in COVID-19 patients.

show abstract

Neutrophil to Lymphocyte Ratio on Admission to Predict Mortality of COVID-19 Elderly Patients

Fenty,

Sukorini

2024

Indonesian J. Clin. Pathol. Med. Lab.

Self Cite

View full text Add to dashboard Cite

Severe Acute Respiratory Syndrome Corona Virus Disease-2 (SARS-COV-2) is the cause of COVID-19, which led to a global pandemic and high mortality rate, especially in elderly patients. The declining immune system in elderly patients and comorbid diseases lead to more severe symptoms and an increased mortality rate. Many studies have shown that a high Neutrophil-Lymphocyte Ratio (NLR) value can predict the severity and mortality of COVID-19. However, studies on NLR in elderly patients in Indonesia have rarely been conducted. This study aimed to determine the role of NLR on admission as a mortality predictor in COVID-19 elderly patients who underwent in-hospital treatment. This research is an analytical observational study with a retrospective cohort method conducted in Bethesda Hospital, Yogyakarta, Indonesia. The research subjects were selected from July 2020 to October 2021 according to inclusion and exclusion criteria. Inclusion criteria were all elderly COVID-19 patients with an age limit of > 60 years old who had complete hemogram data on admission, demographic data, diagnostic criteria, types of comorbid diseases, and patient outcomes (survivor or non-survivor). The exclusion criteria were elderly COVID-19 patients with incomplete Electronic Medical Records (EMR). This study found 122 elderly patients with COVID-19 with a mortality rate of 30.33%. The result showed that NLR on admission significantly increased significantly in the non-survivor group compared to the survivor group. Multivariate Cox regression analysis presented severity (RR: 5.181; CI 1.662-16.154; p=0.005), comorbid diabetes mellitus (RR: 2.829; CI: 1.115-7.178), NLR > 6.04 (RR: 6.356; CI: 2.428-16.639) and other comorbid, namely thyroid, autoimmune, cancer, and anemia (RR: 15.836; CI: 1.841-136.234; p=0.012) as factors of mortality in hospitalized elderly patients.

show abstract

Hubungan Komorbiditas Terhadap Derajat Keparahan Admisi Dan Outcome Pasien Covid-19

Cited by 3 publications

References 3 publications

The Relationship of Hypertension with Death in Covid-19 Patients Treated at Tugurejo Hospital Semarang

The Relationship of Hypertension with Death in Covid-19 Patients Treated at Tugurejo Hospital Semarang

Relationship of Comorbidity and Age to the Severity of Clinical Symptoms of COVID-19 at Mataram University Hospital

Neutrophil to Lymphocyte Ratio on Admission to Predict Mortality of COVID-19 Elderly Patients

Contact Info

Product

Resources

About